PRKAA1 and breast carcinoma: In MCF7 and MDA-MB-231 breast cancer cells, honokiol treatment increases AMPK phosphorylation and activity and the expression of its downstream targets, including acetyl-coenzyme A carboxylase and phosphorylated p70S6 kinase, which suppresses migration and invasion [32].